SHS may further participate in developing both stroke subtypes by modulating various channel activities and gene expression, such as activating calcium-dependent potassium channels and upregulating matrix metalloproteinase expression (e.g., MMP-2 and MMP-9) (22–24). The gene discussed is MMP9; the disease is Stroke.